Pharmacol Res Perspect. 2018;6(6):e00439. doi:10.1002/prp2.439 Food and Drug Administration. Statins: drug safety communication - FDA requests removal of strongest warning against using ...
(and related companies) and Ranbaxy Inc. (and related companies) in an antitrust lawsuit involving a generic version of cholesterol drug Lipitor. The lawsuit alleged the two companies conspired to ...
But in a study published in Science Advances, researchers at Case Western Reserve University describe how they may have found a new target: a cholesterol-managing protein called PfNCR1.
According to West Virginia Attorney General Patrick Morrisey, a $17 million settlement between the state, Pfizer, and Ranbaxy has been approved. The antitrust lawsuit involved a generic, cheaper ...